CogT pSOPT Intervention Study

Inclusion criteria

• criteria related to defining "mild cognitive impairment": a. Presence of memory complaint; b. Rey Auditory Verbal Learning Test delayed recall (for memory) < 59% of age-adjusted norm; c. Montreal Cognitive Assessment (for global cognition) ranged 18 and 27; d. Functional Assessment Questionnaire (for activities of daily living) < 20.
• intact score for San Diego Brief Assessment of Capacity to Consent (UBACC).
• if a participant is on AD medication (i.e., memantine, cholinesterase inhibitors, amyloid antibodies), antidepressants, anxiolytics, or vascular risk or diseases related medications (e.g., beta-blocker), the dose should be stable for 3 months prior to recruitment.
• age 60+,
• read and understand English
• adequate visual and hearing acuity for testing by self-report,
• community-dwelling (including independent living).

Exclusion criteria

• current enrollment in another cognitive improvement study;
• uncontrollable major depression;
• major cerebrovascular and cardiovascular diseases (e.g., congestive heart failure, pacemaker, prior myocardial infarction);
• having an active legal guardian (indicating impaired capacity for decision making);
• currently pregnant
• 3T MRI contraindication
• Neurological conditions: Neurodegenerative disease diagnosis such as Parkinson's, Alzheimers, dementia, multiple sclerosis. Of note, other neurological conditions/injury such as stroke, seizures, traumatic brain injury, will be evaluated for inclusion/exclusion on a case-by-case basis based on event recency, severity, and recovery.